State may fund stem cell work

If budget is passed, New Jersey will be first US state to invest in stem cell research

Written byTheresa Tamkins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

New Jersey could become the first state in the US to use public funds for stem cell research, according to a budget proposal announced Tuesday (February 24) by Governor James McGreevey.

“Today, I propose to go where no other state has gone—to invest state funds in your courage and the hopes of so many families—with the creation of a new research institute, the New Jersey Institute for Stem Cell Research,” said McGreevey in his budget address.

The Institute would be a joint project of the University of Medicine and Dentistry of New Jersey (UMDNJ) and Rutgers University and would be located in New Brunswick. The budget earmarks $6.5 million in state funds to be the included in a $10 million public/private stem cell fund, which will be used to attract top researchers from around the world. An additional $50 million in public and private funds will be used to support ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies